Top Navy admiral, successfully treated for breast cancer, ceded authorities briefly
Adm. Lisa Franchetti, chief of Naval Operations, was successfully treated for breast cancer in July, the Navy announced ...
Navy’s top admiral recently treated for breast cancer, service announces
The Navy said the service's top admiral is "cancer-free" after surgery last summer and follow-up radiation therapy.
Navy Times1h
Navy’s top officer treated successfully for breast cancer
Adm. Lisa Franchetti's stage 1 breast cancer was discovered during a routine mammogram in June and she underwent outpatient ...
Navy’s highest-ranking officer successfully treated for breast cancer
Chief of Naval Operations Adm. Lisa Franchetti was treated successfully for early-stage breast cancer this summer, the ...
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ Drugs
FDA approves Lilly's eczema drug, Ebglyss, and the expanded use of Novartis' Kisqali, Merck's Keytruda and AstraZeneca's Fasenra.
Navy Reveals Top Admiral Was Treated for Breast Cancer in July and Briefly Sidelined
Chief of Naval Operations Adm. Lisa Franchetti, the Navy's top officer, received a diagnosis of stage 1 breast cancer in late ...
Stars and Stripes3h
Navy’s top admiral announces she is cancer free after breast cancer treatment
Franchetti, the chief of naval operations, was diagnosed with Stage 1 breast cancer in June. She is the first woman to ...
Top US Navy officer successfully treated for breast cancer
Admiral Lisa Franchetti, the first woman to lead the US Navy, has been treated for breast cancer and is free of the disease, ...
USNI3h
CNO Franchetti is Healthy After Treatment for Stage 1 Breast Cancer
The Navy’s top officer is healthy after treatment following a Stage 1 breast cancer diagnosis earlier this year, the service ...
Mena FN7h
How Critical Demand For Metastatic Breast Cancer Therapies Is Producing A Multi-Billion Dollar Opportunity For Biotechs - Financial News Media
Breast cancer develops due to reasons ... pharma companies in the markets this week include Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), Novartis AG (NYSE: NVS), Merck (NYSE: MRK), Pfizer Inc. ...
TMCnet8h
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...